CD20, Human (Ofatumumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD20, Human (Ofatumumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD20, Human (Ofatumumab biosimilar)
CloneOfatumumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD20 Recombinant Antibody (Ofatumumab). Ofatumumab, sold under the brand name Arzerra among others, is a fully human monoclonal antibody to CD20, which appears to inhibit early-stage B lymphocyte activation. It is FDA approved for treating chronic lymphocytic leukemia that is refractory to fludarabine and alemtuzumab (Campath) and for the treatment of multiple sclerosis.
Immunogenn/a
Other NamesAnti-CD20 Recombinant Antibody, Research Grade Ofatumumab, Anti-Human CD20 Recombinant Antibody(Ofatumumab), HuMax-CD20, Antibody Drug Analogues, Monoclonal Antibody, YR1129, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 679818-59-8
Catalog #YR1129
Priceplease inquire
Order / More InfoCD20, Human (Ofatumumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.